Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 10/5/2006 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Achim Knappik?

Achim Knappik

Senior Director Research and Development

A-by-D

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Senior Director of Research and Development

Antibodies


Head

R&D


Research and Development Group Manager

Bio-Rad Laboratories Inc


Head of Research and Development

AbD Serotec Ltd


Senior Director

MorphoSys AG


Web References(26 Total References)


AbD Serotec

www.a-by-d.com [cached]

Achim Knappik and Hartmut Merzby Achim Knappik, Bettina Boelter and Hartmut MerzAchim Knappik, PhD, Senior Director R&D of A-by-D, speaks to NGP about the benefits of new antibody design technologiesCHEManager, 11/2004, Vol 4, Reprint, pp32-33 : Screening Trends in Drug Discovery"From Antigen Sequence to Antibody in Record Time.Two Innovative Technologies Combined for the High-Throughput..."Achim Knappik and Christoph Hüls"Achim Knappik, Hartmut Merz (Medizinische Universität Schleswig Holstein, Campus Lübeck)Dr. Achim Knappik : "Synthetic Recombinant Antibodies" (in japanese language)


www.abdserotec.com

Achim Knappik, PhD, Senior Director R&D of A-by-D, speaks to NGP about the benefits of new antibody design technologies


www.abdserotec.com

Dr Achim Knappik of AbD Serotec describes the use of recombinant anti-idiotypic antibodies as specialized tools in the development of preclinical and clinical research assays for antibody drug development and how they are generated using proprietary HuCAL® recombinant antibody generation technology.


www.abdserotec.com

Hear how AbD Serotec's HuCAL ® technology can be used to generate recombinant anti-drug antibodies for PK and immunogenicity assays in a presentation by Dr Achim Knappik, Head of R&D.


www.oem.abdserotec.com

Dr. Achim Knappik, Head of R&D at AbD Serotec commented, "Today's news further exemplifies the unique flexibility of our HuCAL antibody platform and the broad range of potential applications which we can target. e2v's approach to establish a novel type of point of care system is highly innovative and very interesting both scientifically and commercially.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory